SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Apr-23 9:05 PM View: | Outlook Therapeutics, Inc. (OTLK) | 20-Apr-23 | Sale | 520,000 | $1.13 | $590,200.00 | (44%) 1.17M to 653.06K | |
23-Jun-22 5:08 PM View: | Outlook Therapeutics, Inc. (OTLK) | 21-Jun-22 | Private Purchase | 10,000 | $1.05 | $10,500.00 | < 1% 1.16M to 1.17M | |
06-Dec-21 5:26 PM View: | Outlook Therapeutics, Inc. (OTLK) | 06-Dec-21 | Private Purchase | 25,201 | $1.38 | $34,777.40 | 2% 1.14M to 1.16M | |
03-Dec-21 4:32 PM View: | Outlook Therapeutics, Inc. (OTLK) | 03-Dec-21 | Private Purchase | 10,000 | $1.42 | $14,200.00 | < 1% 1.13M to 1.14M | |
25-Feb-21 8:51 PM View: | Outlook Therapeutics, Inc. (OTLK) | 23-Feb-21 | Market Sale | 15,900 | $2.09 | $33,199.20 | (1%) 1.14M to 1.13M | (10%) |
17-Feb-21 9:13 PM View: | Outlook Therapeutics, Inc. (OTLK) | 12-Feb-21 | Market Sale | 63,700 | $2.55 | $162,435.00 | (5%) 1.21M to 1.14M | (8%) |
21-Apr-20 6:40 PM View: | Outlook Therapeutics, Inc. (OTLK) | 19-Mar-20 | Grant | 1,207,460 | -- | -- | 100% 0 to 1.21M |